VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 102 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,595 | +12.8% | 76,941 | -6.9% | 0.00% | – |
| Q4 2022 | $8,509 | -29.1% | 82,615 | +7.5% | 0.00% | – |
| Q3 2022 | $12,000 | -83.6% | 76,867 | -7.7% | 0.00% | – |
| Q2 2022 | $73,000 | -29.1% | 83,275 | +0.5% | 0.00% | – |
| Q1 2022 | $103,000 | -50.5% | 82,887 | -22.2% | 0.00% | – |
| Q4 2021 | $208,000 | -26.5% | 106,578 | +3.3% | 0.00% | – |
| Q3 2021 | $283,000 | -66.0% | 103,192 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $832,000 | – | 264,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,736,283 | $22,886,000 | 9.62% |
| VR Adviser, LLC | 16,047,286 | $31,292,000 | 4.28% |
| COMMODORE CAPITAL LP | 8,464,999 | $16,507,000 | 3.82% |
| Ghost Tree Capital, LLC | 2,000,000 | $3,900,000 | 1.40% |
| EPIQ PARTNERS, LLC | 1,002,350 | $1,955,000 | 1.04% |
| HighVista Strategies LLC | 577,031 | $1,125,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,024,938 | $7,849,000 | 0.86% |
| NEA Management Company, LLC | 16,302,596 | $31,790,000 | 0.64% |
| Nicholas Investment Partners, LP | 4,288,077 | $8,362,000 | 0.53% |
| Logos Global Management LP | 2,000,000 | $3,900,000 | 0.40% |